A bipartisan House bill would require discounts for drugs in Medicare’s prescription drug program to be applied when the medicine is bought at the pharmacy, an effort to make sure that customers get the full discount instead of a cut going to insurers and drug middlemen.
The Phair Pricing Act of 2018 introduced Thursday builds on parts of a blueprint President Trump released this month to tackle drug pricing. It highlights a lack of transparency in the negotiations over rebates to lower prices for medications in Medicare Part D, the program’s prescription drug plan.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.